All In MedTech

Device Trial Radar · NCT06630637

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

Intermittent Fasting Monitoring for Human Optimization Utilizing Wearable Technology: an N-of-1 Prospective Study

Last checked: Nov 20, 2026Latest source record: Jul 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1

Actual

Start

Oct 7, 2024

Primary completion

Jun 7, 2025

Study completion Jul 2, 2025

Sponsor

Lead sponsor
Institute for Digital Medicine (WisDM)Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 8, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated device
No
Who can join
Male only, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

There is a growing interest in personalized health strategies, including diet, exercise, and fasting regimens, to enhance metabolic fitness. Recent research indicates that intermittent fasting (IF) is useful not only for weight management, but also for energy production and improvement of metabolic well-being. IF can potentially reduce systemic inflammation and help to prevent chronic diseases. IF research can also help athletes sustain performance during fasting periods. This prospective study aims to investigate the effects of a human optimization program on an individual\'s metabolic health and overall well-being. This research examines the correlations between continuous glucose monitoring, ketone measurement, exercise routines, heat/cold interventions, diet, supplements and intermittent fasting patterns. The study involves a single participant -the principal investigator- who will adhere to a personalized regimen involving wearable monitoring of metabolic changes, training and intermittent fasting. This research seeks to understand the potential relationships between these factors, contributing to the emerging knowledge on individualized health optimization.

Conditions

  • Intermittent Fasting
  • Healthy
  • Digital Health

Interventions

  • Glucose-Ketone Index (GKI) monitoringBehavioral

    Ketone and blood glucose monitoring with Abbott Optium Neo up to 10 times per day to observe GKI dynamics for gamification of adherence.

  • Continuous Glucose Monitoring (CGM)Behavioral

    Monitoring with an Abbott Freestyle Libre to observe glucose dynamics for gamification of adherence.

  • Digital dynamometerOther

    Grip strength measurements, right and left hand, up to 20 readings per day per hand.

  • WearablesDevice

    All Apple Watch 9 and Whoop data daily \[heart rate variability (HRV), resting heart rate, cardio recovery, sleep duration, composition (stages of sleep) and analogous scores, potential maximum rate of oxygen consumption attainable during physical exertion (VO2 max), basal metabolic rate and potential respiratory rate\].

  • Blood testsDiagnostic test

    Pre- and Post-fast (48h) testing of lipid panel, ApoB, ApoA1, CRP, interleukin panel, omega 3:6 ratio, and autophagy analysis. Potential CBC, renal and liver panels to be taken where appropriate.

  • Stool testsDiagnostic test

    15 g of stool will be collected from the subject pre- and post-fast for microbiome assessment and pre- and post- the first week (the "three meal phase"). After the first week, the maximum number of tests is four per month (maximum of two fasts, with a pre- and post-fast test for each fast).

  • Saliva testsDiagnostic test

    Saliva samples will be collected from the subject pre- and post-fast for microbiome assessment. Maximum number of tests is four per month (maximum of two fasts, with a pre- and post-fast test for each fast).

  • Fitness interventionBehavioral

    90 minutes of strength and/or cardiovascular training for a minimum of 5 days per week.

  • Cold & heat interventionBehavioral

    Cold plunge: at least 3 days per week, 2 sessions of maximum 5 minutes each (minimum 2 minutes between sessions) at a minimum of 6 degrees Celsius. Potential inclusion of GKI measurements before and after plunge. Heat Therapy: maximum of 2 sessions of 20 minutes each of dry sauna blanket (minimum 5 minutes break between sessions) following the cold plunge intervention.

  • AirofitDevice

    Airofit is a smart breathing training device designed to improve respiratory strength and efficiency. It is used for enhancing sport performance, well-being, and overall health. The device works by providing adjustable resistance to breathing muscles. 5-10 minutes of daily use.

  • 18h fastingBehavioral

    Minimum of 18 hours fasting per day, with feeding window to occur between 5pm-8pm or 12pm-3pm. The fasting procedures will occur only after the Three Meal Phase.

  • 48h fastingBehavioral

    48h fasting maximum twice monthly, at least one week apart. Multivitamin and electrolytes with water, and black coffee or tea (0-calorie drinks) will be consumed.The fasting procedures will occur the Three Meal Phase.

  • Three meal phaseBehavioral

    During the first week of the study, the participant will follow a regime of three meals per day.

  • Mediterranean-inspired dietBehavioral

    Regimen of Mediterranean-inspired nutrition comprised of Olive Oil, Olives, Leafy Green Vegetables, Lean Protein (Beef, Chicken, Lamb, Pork, Duck, Salmon, Tuna), Chia Seeds, Pecans, Macadamia, Pumpkin Seeds, Walnuts, Greek Yogurt, Salt, Pepper, Paprika, Cumin, Garlic powder, onion powder; Fruit: Blueberry, Grapefruit; Carbohydrates: Rolled Oats; Hydration: Water, Black Coffee, Black Tea, Coke Zero and 100 Zero sparingly, Ultima electrolytes. Photographs of meals will be taken to create a visual record of the diet followed. Photographs of the devices will be taken to create a visual record of the blood glucose and ketone concentration results.

  • SupplementsDietary supplement

    Multivitamin (Centrum), Vitamin D (Up to 2000 IU per day), Creatine (Up to 2000mg), Fisetin (1 pill), Omega-3 (1 tablet), Turmeric, Pre-Probiotic, Blueberry Extract, Holy Basil Extract.

  • Generative AIBehavioral

    Feeding ketone data, glucose data (from finger prick and/or CGM), any/all Apple Watch Data, and dietary images into a generative AI platform to convert data into images using any selected prompts, with the intent of the images serving as immediate, visual readouts as a function of activity and/or inactivity.

  • InterviewsOther

    Three interviews, of 30-60 minutes each one, at baseline, end of three meal phase and end of study, to gain insights into the participant's experience. Exploration of daily routines including diet, exercise and the use of technology and aspects of a healthy lifestyle.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Metabolic biomarker analysis: total cholesterol levelsTime frame: Pre and post 48 hour fasts (2 fasts per month for 12 months)
  2. Metabolic biomarker analysis: low density lipoprotein (LDL) cholesterol levelsTime frame: Pre and post 48 hour fasts (2 fasts per month for 12 months)
  3. Metabolic biomarker analysis: high density lipoprotein (HDL) cholesterol levelsTime frame: Pre and post 48 hour fasts (2 fasts per month for 12 months)

36 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Institute for Digital Medicine (WisDM)

    Singapore, Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.